Abstract
Current guidelines suggest an early invasive strategy (EIS) over an initial conservative strategy (ICS) in non-ST elevation acute coronary syndrome (NSTE-ACS), particularly for high-risk patients. However, individual randomized controlled trials (RCTs) have shown contrasting results and a definite
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
